Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

ROBERT A VESCIO

Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology

NPI
1962509216
CMS profile
179408
Location
WEST HOLLYWOOD, CA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2022 · Entire year

$205,757.12

169 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2022 · entire year · sorted by reported total

By paying entity

PY2022 · entire year · sorted by reported total

Paying entityAmountRecords
E.R. Squibb & Sons, L.L.C. $112,383.63 93
GlaxoSmithKline, LLC. $47,733.76 26
Janssen Biotech, Inc. $16,179.30 16
Amgen Inc. $10,279.50 11
Karyopharm Therapeutics Inc. $9,805.18 6
Alnylam Pharmaceuticals Inc. $7,547.66 11
Takeda Pharmaceuticals U.S.A., Inc. $1,177.50 1
Celgene Corporation $300.00 1
Janssen Scientific Affairs, LLC $135.58 2
SANOFI-AVENTIS U.S. LLC $117.49 1
PFIZER INC. $97.52 1

Page 2 of 4; records 51–100 of 169 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

ROBERT A VESCIO

NPI 1962509216 · CMS profile ID 179408

Allopathic & Osteopathic Physicians / Internal Medicine / Hematology & Oncology

WEST HOLLYWOOD, CA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 2 of 4; records 51–100 of 169 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1962509216?year=2022&recipient=provider&page=2#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
ROBERT A VESCIO, NPI 1962509216, CMS profile ID 179408. General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 4; records 51–100 of 169 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1962509216?year=2022&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c.
APA 7
IndustryPayments. (2026). ROBERT A VESCIO, NPI 1962509216, CMS profile ID 179408. General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 4; records 51–100 of 169 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1962509216?year=2022&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c.
Bluebook
ROBERT A VESCIO, NPI 1962509216, CMS profile ID 179408, IndustryPayments, General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 2 of 4; records 51–100 of 169 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c. https://industrypayments.org/provider/npi-1962509216?year=2022&recipient=provider&page=2#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2022

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2022 · Physicians and non-physician practitioners · CMS publication 2026-06-30

169 matching records · $205,757.12 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 169 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 51–100 of 169.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
E.R. Squibb & Sons, L.L.C. $161.9609/21/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 932520843 CMS
SANOFI-AVENTIS U.S. LLC $117.4909/20/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 938768153 CMS
E.R. Squibb & Sons, L.L.C. $2,768.0009/13/2022 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 932520711 CMS
Janssen Biotech, Inc. $550.0009/13/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 885558177 CMS
E.R. Squibb & Sons, L.L.C. $27.0009/06/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 932520713 CMS
E.R. Squibb & Sons, L.L.C. $17.8209/06/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 932520715 CMS
GlaxoSmithKline, LLC. $160.9608/31/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 945068053 CMS
GlaxoSmithKline, LLC. $119.4008/31/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 945068067 CMS
E.R. Squibb & Sons, L.L.C. $4,310.0008/30/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 932520719 CMS
E.R. Squibb & Sons, L.L.C. $8.2608/23/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 932520879 CMS
E.R. Squibb & Sons, L.L.C. $54.0008/23/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 932520881 CMS
Janssen Biotech, Inc. $105.6008/15/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 885558187 CMS
E.R. Squibb & Sons, L.L.C. $141.9508/10/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 932520717 CMS
E.R. Squibb & Sons, L.L.C. $277.9608/10/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 932520721 CMS
E.R. Squibb & Sons, L.L.C. $938.6408/10/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 932520723 CMS
E.R. Squibb & Sons, L.L.C. $124.9908/10/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 932520725 CMS
E.R. Squibb & Sons, L.L.C. $5,510.0008/02/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 932520877 CMS
GlaxoSmithKline, LLC. $27.0008/02/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 945068035 CMS
GlaxoSmithKline, LLC. $4,800.0007/26/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 945068061 CMS
Amgen Inc. $1,200.0007/22/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 939905677 CMS
E.R. Squibb & Sons, L.L.C. $531.1007/20/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 932520873 CMS
E.R. Squibb & Sons, L.L.C. $105.6807/20/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 932520875 CMS
E.R. Squibb & Sons, L.L.C. $312.5007/20/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 932520883 CMS
E.R. Squibb & Sons, L.L.C. $2,162.3607/20/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 932520885 CMS
Janssen Scientific Affairs, LLC $29.0907/14/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 887183443 CMS
Karyopharm Therapeutics Inc. $4,000.0007/13/2022 Honoraria No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 946527791 CMS
Karyopharm Therapeutics Inc. $115.6907/13/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 946527797 CMS
Amgen Inc. $131.0406/30/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 939905679 CMS
GlaxoSmithKline, LLC. $206.2006/29/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 945068057 CMS
GlaxoSmithKline, LLC. $109.4406/29/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 945068071 CMS
GlaxoSmithKline, LLC. $906.9506/29/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 945068081 CMS
Amgen Inc. $3,600.0006/28/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 939905681 CMS
Amgen Inc. $600.0006/28/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 939905683 CMS
Amgen Inc. $116.0706/22/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 939905685 CMS
E.R. Squibb & Sons, L.L.C. $70.2006/21/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 932520671 CMS
GlaxoSmithKline, LLC. $50.0006/21/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 945068033 CMS
GlaxoSmithKline, LLC. $1,600.0006/21/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 945068077 CMS
GlaxoSmithKline, LLC. $4,800.0006/21/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 945068079 CMS
Celgene Corporation $300.0006/15/2022 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 932520921 CMS
GlaxoSmithKline, LLC. $1,200.0006/14/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 945068073 CMS
E.R. Squibb & Sons, L.L.C. $257.4006/13/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 932520667 CMS
E.R. Squibb & Sons, L.L.C. $4,310.0006/07/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 932520669 CMS
E.R. Squibb & Sons, L.L.C. $4,310.0006/07/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 932520677 CMS
E.R. Squibb & Sons, L.L.C. $27.8106/07/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 932520823 CMS
E.R. Squibb & Sons, L.L.C. $65.1806/07/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 932520827 CMS
GlaxoSmithKline, LLC. $270.8805/25/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 945068037 CMS
GlaxoSmithKline, LLC. $124.4205/25/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 945068043 CMS
GlaxoSmithKline, LLC. $880.9705/25/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 945068047 CMS
E.R. Squibb & Sons, L.L.C. $125.0005/24/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 932520673 CMS
E.R. Squibb & Sons, L.L.C. $124.9905/18/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 932520665 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $156,082.47 136
PY2020 $126,679.86 94
PY2021 $211,338.75 156
PY2022 $205,757.12 169
PY2023 $166,157.06 158
PY2024 $135,480.23 141
PY2025 $137,552.43 120

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Recipient $950.00 2
PY2025 Principal investigator $12,548.97 3
PY2024 Principal investigator $53,349.05 7
PY2023 Principal investigator $31,783.48 2
PY2019 Recipient $5,594.20 3

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

5 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Recipient PFIZER INC. $620.00 11/10/2025 Covered Recipient Physician ELRANATAMAB CLINICAL PUBLICATION PROGRAM No dispute reported 06/30/2026 1228726933
Recipient PFIZER INC. $330.00 08/05/2025 Covered Recipient Physician ELRANATAMAB CLINICAL PUBLICATION PROGRAM No dispute reported 06/30/2026 1228726931
Principal investigator 1 PFIZER INC. $5,498.03 04/16/2025 Covered Recipient Teaching Hospital
CEDARS-SINAI MEDICAL CENTER
A PHASE 1B2 OPEN LABEL UMBRELLA STUDY OF ELRANATAMAB PF06863135 A BCELL MATURATION ANTIGEN BCMA CD3 BISPECIFIC ANTIBODY IN COMBINATION WITH OTHER ANTICANCER TREATMENTS IN PARTICIPANTS WITH MULTIPLE MYELOMA No dispute reported 06/30/2026 1228796489
Principal investigator 1 PFIZER INC. $3,973.72 03/22/2025 Covered Recipient Teaching Hospital
CEDARS-SINAI MEDICAL CENTER
A PHASE 1B2 OPEN LABEL UMBRELLA STUDY OF ELRANATAMAB PF06863135 A BCELL MATURATION ANTIGEN BCMA CD3 BISPECIFIC ANTIBODY IN COMBINATION WITH OTHER ANTICANCER TREATMENTS IN PARTICIPANTS WITH MULTIPLE MYELOMA No dispute reported 06/30/2026 1228782799
Principal investigator 1 PFIZER INC. $3,077.22 01/25/2025 Covered Recipient Teaching Hospital
CEDARS-SINAI MEDICAL CENTER
A PHASE 1B2 OPEN LABEL UMBRELLA STUDY OF ELRANATAMAB PF06863135 A BCELL MATURATION ANTIGEN BCMA CD3 BISPECIFIC ANTIBODY IN COMBINATION WITH OTHER ANTICANCER TREATMENTS IN PARTICIPANTS WITH MULTIPLE MYELOMA No dispute reported 06/30/2026 1228799744